The ethics of pay-to-play clinical trials are a minefield. Last week the HHS Secretary’s Advisory Committee on Human Research Protections (SACHRP) stepped into that minefield. Are “pay-to-play” clinical trials ever ethically acceptable?
Search: “stanislaw burzynski”
We found 410 results for your search.
Stem cell therapies show great promise, but as yet the vast majority of that promise has not been validated in rigorous clinical trials. Unfortunately, for-profit stem cell clinics are running clinical trials that require patients to pay to be part of them (“pay-to-play”). These trials are not rigorous. Even more unfortunately, it appears that some universities are also running “pay-to-play” clinical trials that bear an uncomfortable resemblance to those run by for-profit clinics.
Share this:
For once, Twitter actually changed Orac’s mind. Chronic Lyme disease is not a fake disease. Rather, it is a fake diagnosis or pseudodiagnosis disconnected from what is really going on physiologically. That’s why only quacks use the diagnosis.
Share this:
The Oncology Association of Naturopathic Physicians (OncANP) writes a “sttaement of principles” guideline for naturopathic oncology. How can you write a statement of principles for quackery? More importantly, why would a real oncology journal publish it?
Share this:
I’ve written twice before about German alternative medicine cancer clinics, the quackery they ply, and how they take advantage of desperate cancer patients. Finally, in a disturbing report a journalist has investigated what one of these clinics (Hallwang) does and how such clinics can continue to operate.
